⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19388119 | 0.76 | — | — | |
| SCHEMBL29226186 | 0.73 | LMNA (0.40) | — | |
| SCHEMBL29381833 | 0.67 | PTGS1 (0.37) | — | |
| SCHEMBL29381823 | 0.67 | PTGS1 (0.37) | — | |
| SCHEMBL11661286 | 0.67 | — | — | |
| SCHEMBL19737583 | 0.67 | — | — | |
| SCHEMBL5340662 | 0.67 | — | — | |
| SCHEMBL30111322 | 0.65 | — | — | |
| SCHEMBL16446125 | 0.65 | CTH (0.31) | — | |
| SCHEMBL23872517 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4652459-A2 | CALCIUM INDEPENDENT PHOSPHATIDYLSERINE BINDING COMPOUNDS FOR DETECTING PHOSPHATIDYLSERINE POSITIVE CELLS | Biolegend, Inc. (US) | 2025-11-26 | — | — | EP | claimed |
| US-20240262865-A1 | Calcium independent phosphatidylserine binding compounds for detecting phosphatidylserine positive cells | BioLegend, Inc. | 2024-08-08 | — | — | US | claimed |
| WO-2024155787-A2 | CALCIUM INDEPENDENT PHOSPHATIDYLSERINE BINDING COMPOUNDS FOR DETECTING PHOSPHATIDYLSERINE POSITIVE CELLS | ZHANG HONG (US) | 2024-07-25 | — | — | WO | claimed |
| CN-101492494-A | Integrin ligand cyclic peptide analogues and cyclization method | UNIV ZHEJIANG (CN) | 2009-07-29 | — | — | CN | claimed |
| EP-4652459-A2 | CALCIUM INDEPENDENT PHOSPHATIDYLSERINE BINDING COMPOUNDS FOR DETECTING PHOSPHATIDYLSERINE POSITIVE CELLS | Biolegend, Inc. (US) | 2025-11-26 | — | — | EP | disclosed |
| WO-2025076243-A1 | CELL-TARGETING COMPLEXES AND USES THEREOF | IONIS PHARMACEUTICALS, INC. (US) | 2025-04-10 | — | — | WO | disclosed |
| US-20240262865-A1 | Calcium independent phosphatidylserine binding compounds for detecting phosphatidylserine positive cells | BioLegend, Inc. | 2024-08-08 | — | — | US | disclosed |
| WO-2024155787-A2 | CALCIUM INDEPENDENT PHOSPHATIDYLSERINE BINDING COMPOUNDS FOR DETECTING PHOSPHATIDYLSERINE POSITIVE CELLS | ZHANG HONG (US) | 2024-07-25 | — | — | WO | disclosed |
| CN-105358708-B | Use of CD36 to identify cancer subjects for treatment | 儿童医学中心公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-118028464-A | Use of CD36 to identify cancer subjects for treatment | 儿童医学中心公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-118028463-A | Use of CD36 to identify cancer subjects for treatment | 儿童医学中心公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-112824878-B | Anchoring method of target biological molecules, expansion microscopic imaging method and application thereof | 北京大学 | 2021-12-03 | — | — | CN | disclosed |
| WO-2010057220-A1 | PREPARATION OF DIAZO AND DIAZONIUM COMPOUNDS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2010-05-20 | — | — | WO | disclosed |
| US-20100125132-A1 | PREPARATION OF DIAZO AND DIAZONIUM COMPOUNDS | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2010-05-20 | — | — | US | disclosed |
| EP-2182974-A2 | CYCLIC AZAPEPTIDES AS INTEGRIN MARKERS | Siemens Medical Solutions USA, Inc. (US) | 2010-05-12 | — | — | EP | disclosed |
| US-20100048866-A1 | WATER-SOLUBLE PHOSPHINOTHIOL REAGENTS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-02-25 | — | — | US | disclosed |
| CN-101492494-A | Integrin ligand cyclic peptide analogues and cyclization method | UNIV ZHEJIANG (CN) | 2009-07-29 | — | — | CN | disclosed |
| CN-101492494-A | Integrin ligand cyclic peptide analogues and cyclization method | UNIV ZHEJIANG (CN) | 2009-07-29 | — | — | CN | disclosed |
| US-20090074664-A1 | CYCLIC AZAPEPTIDES AS INTEGRIN MARKERS | SIEMENS MEDICAL SOLUTIONS USA, INC. | 2009-03-19 | — | — | US | disclosed |
| WO-2009018175-A2 | CYCLIC AZAPEPTIDES AS INTEGRIN MARKERS | SIEMENS MEDICAL SOLUTIONS USA, INC. (US) | 2009-02-05 | — | — | WO | disclosed |